B. L. CHENARD - Concepedia

Concepedia

Author

B. L. CHENARD

Pfizer (United States)

Also Known As

B L Chenard, B. L. CHENARD, B. L. Chenard, B.L Chenard, B.L. Chenard, Bert Chenard, Bert L. Chenard

56

Publications

1.9K

Citations

21

H-Index

43

Concepts

All Affiliations

Pfizer (United States)DuPont (United States)

BL

About

B. L. CHENARD is an author at Pfizer (United States) specializing in chemistry, organic chemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	765
2	Engineering	9	9	922
3	Biochemistry	9	9	663
4	Natural Sciences	7	7	591
5	Biomolecular Engineering	3	3	273

B. L. CHENARD

×

24

Publications

1.9K

Citations

21

H-Index

	Year	Citations
Metal silanolates: organic soluble equivalents for O−2 Evan D. Laganis, B. L. CHENARD Tetrahedron Letters Metal SilanolatesInorganic ChemistryEngineeringOrganic ChemistryOrganometallic Catalysis	1984	222
(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate Responses B. L. CHENARD, J. Bordner, Todd W. Butler, Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryFunctional SelectivityMedicineNatural Sciences	1995	179
Equilibration of the Oxidative Addition Product of Tetrakis(triphenylphosphine)palladium and Electron-Rich Aryl Halides Leads to Product Scrambling in the Stille Reaction Barb E. Segelstein, Todd W. Butler, B. L. CHENARD The Journal of Organic Chemistry Stille ReactionCross-coupling ReactionDerivative (Chemistry)EngineeringAlkene Metathesis	1995	175
Synthesis, structure, and properties of pentathiepins B. L. CHENARD, Richard L. Harlow, A.L. Johnson, Journal of the American Chemical Society AltmetricsMedicinal ChemistryPharmaceutical ChemistryEngineeringDonut Icon	1985	144
Separation of .alpha.1-adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds B. L. CHENARD, Ismail A. Shalaby, B. Kenneth Koe, Journal of Medicinal Chemistry	1991	141
Antagonists Selective for NMDA Receptors Containing the NR2B Subunit B. L. CHENARD, Frank S. Menniti Current Pharmaceutical Design Nr2b SubunitFunctional SelectivityMedicineReceptor (Biochemistry)Nmda Receptor	1999	140
Silylstannanes in organic synthesis. Scope and limitation of palladium-catalyzed reaction with acetylenes B. L. CHENARD, C. M. Van Zyl The Journal of Organic Chemistry Chemical EngineeringCross-coupling ReactionEngineeringAltmetric Attention ScoreOrganic Chemistry	1986	134
Atropisomeric quinazolin-4-one derivatives are potent noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists W. M. WELCH, Frank E. Ewing, J. HUANG, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryAtropisomeric Quinazolin-4-one DerivativesMedicineReceptor Antagonists	2001	123
Silyl stannanes: useful reagents for bis-functionalization of .alpha.,.beta.-unsaturated ketones and acetylenes B. L. CHENARD, Evan D. Laganis, F. Davidson, The Journal of Organic Chemistry EngineeringChemical AnalysisAltmetric Attention ScoreOrganic ChemistryChemistry	1985	98
Benzopentathiepins: synthesis via thermolysis of benzothiadiazoles with sulfur B. L. CHENARD, T.J. Miller The Journal of Organic Chemistry Diversity Oriented SynthesisMolecular SciencesDonut IconAltmetric Attention ScoreOrganic Chemistry	1984	69

Page 1